For this reason Richter is continuously expanding the range of its cardiological products. Its ACE-inhibitor product for the lowering of blood pressure, launched in 1995, has become the most frequently administered medicine in Hungary, seven years after its introduction. Another of Richter’s ACE-inhibitor products, also popular in the Hungarian and international markets, has provided the medical profession with a long-acting active ingredient with unique kinetic properties, for the protection of organs, while a still more recently introduced medicine offers the outstanding efficacy of a third-generation calcium antagonist. A combination of the latter two medicines has been awarded the Innovation Grand Prize of the Hungarian Association for Innovation, and by combining the two effects, makes it possible to achieve even better results in the fight against cardiovascular disease. Besides these, the Company’s newest product enables doctors to provide their patients with a modern statin therapy for the reduction of cholesterol. 

This page has been prepared to provide information to patients. The data presented should not be used to reach a diagnosis.

In case you exhibit the symptoms above, consult your doctor immediately!

In order to learn about potential risks and side effects, please read the patient information leaflet or consult your doctor, pharmacist.